Natural Capsules Limited — Updates, 05-08-2025: Press Release

Natural Capsules reported Q1FY26 revenue of ₹ 45.20 Cr, posting a PAT loss of (₹ 5.58 Cr) and EPS of (₹ 5.40). The loss was primarily due to expenses from the newly capitalized API facility. Management noted stable capsules business realisations and moderating gelatin prices, expected to boost future profitability. The company plans to commercialize two new HPMC production lines, driven by robust demand from US duties on Chinese HPMC. In API, higher realisations for steroidal APIs are emerging, with plans to scale capacity by Q2 and achieve cash breakeven for the facility's first full year, targeting higher-margin opportunities.